查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513335

痤疮治疗药物市场：按治疗层级、按配方、按类型、按痤疮类型、按分销管道：2024-2035 年全球机会分析和行业预测

Acne Medication Market By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
2023年全球痤疮治疗药物市场价值为134亿美元，预计2024年至2035年复合年增长率为5.1%，到2035年达到242亿美元。痤疮是一种常见的皮肤病，其特征是形成丘疹、黑头、白斑、囊肿和结节，通常出现在脸部、胸部、背部和肩部。当毛囊被皮脂和死皮细胞堵塞，导致细菌生长和发炎时，就会出现痤疮。痤疮的形成涉及多种因素，包括荷尔蒙波动、遗传、皮脂分泌过多、细菌以及某些药物和化妆品。治疗方法包括类视色素A、抗生素、水杨酸、过氧化苯甲酰和其他药物。
痤疮药物市场-IMG1
由于痤疮发病率上升和不健康饮食，预计痤疮药物市场将显着增长。痤疮是全世界最常见的皮肤病之一，影响所有年龄、性别和种族的人。由于荷尔蒙变化、环境影响、饮食习惯和生活方式选择等因素，其盛行率多年来稳步上升。根据国家医学图书馆 2023 年发表的一篇论文，寻常性痤疮在青少年和年轻人中很常见。据估计，青少年寻常性痤疮的盛行率为 35% 至 90% 以上。此外，不健康的生活方式是痤疮治疗药物市场的关键驱动因素。不良饮食、高压力、睡眠不足和接触环境污染物等生活方式因素会导致痤疮的发生和恶化。富含精製糖、加工食品和乳製品的不均衡饮食会导致荷尔蒙波动并增加皮脂分泌。此外，压力水平的增加会刺激皮质醇等压力荷尔蒙的分泌，引起发炎并使现有的痤疮病变恶化。根据美国焦虑与忧郁症协会 2023 年的一篇报导，整体焦虑症影响着 680 万成年人，即美国人口的 3.1%。此外，睡眠不足会破坏身体的自然癒合过程并削弱免疫系统，使您更容易受到细菌感染和与痤疮相关的发炎。因此，不健康的生活方式导致痤疮发病率增加以及对痤疮治疗药物的需求增加。痤疮治疗市场按治疗层级、配方、类型、痤疮类型、分销管道和地区进行细分。依治疗层级，市场分为类视色素A、抗生素、水杨酸、过氧化苯甲酰等。依剂型划分，市场分为外用药物和内服药物。按类型划分，市场分为处方药和非处方药。依痤疮类型，市场分为非发炎痤疮和发炎痤疮。依分销管道分为零售店、药局/药局和电子商务。按地区划分，北美（美国、加拿大、墨西哥）、欧洲（德国、法国、英国、义大利、西班牙、其他欧洲国家地区）、亚太地区（日本、中国、澳洲、印度、韩国、其他亚洲地区） -太平洋地区），在亚太地区（巴西、沙乌地阿拉伯、非洲和其他欧洲国家）进行分析。痤疮治疗药物市场的主要主要企业有 Bausch Health Companies Inc、Mayne Pharma Group Limited、Sun Pharmaceutical Industries Limited、Johnson and Johnson、GlaxoSmithKline Plc、Mylan NV、Almirall Sa、Galderma SA、Teva Pharmaceutical Industries Ltd.、Pfizer Inc 。主要企业正在采用收购作为关键发展策略，以改善产品系列。

相关人员的主要利益

  • 该报告定量分析了 2023 年至 2035 年痤疮药物市场分析的细分市场、当前趋势、估计/趋势和动态，并确定了痤疮药物市场的强大机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析强调买家和供应商帮助相关人员做出利润驱动的商业决策并加强供应商-买家网路的力量。
  • 对痤疮治疗药物市场细分的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前位置的清晰了解。
  • 该报告包括对区域和全球痤疮治疗药物市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章：痤疮治疗药物市场：依治疗层级

  • 概述
  • 类视色素A
    • 按类型分類的类类视色素A痤疮药物市场
  • 抗生素
    • 按类型分類的抗生素痤疮治疗市场
  • 水杨酸
  • 过氧化苯甲酰
  • 其他药品

第五章痤疮治疗药物市场：按配方

  • 概述
  • 外用製剂
  • 口腔医学

第六章痤疮治疗药物市场：按类型

  • 概述
  • 处方药
  • 非处方药物

第七章痤疮治疗药物市场：按痤疮类型

  • 概述
  • 非发炎痤疮
  • 发炎痤疮

第八章痤疮治疗药物市场：按分销管道

  • 概述
  • 零售店
  • 药局/药局
  • 电子商务

第九章痤疮治疗药物市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 澳洲
    • 印度
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第10章竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2023年主要企业定位

第十一章 公司简介

  • AbbVie Inc.
  • Botanix Pharmaceuticals
  • Galderma SA
  • Bausch Health Companies Inc
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Kenvue Inc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mayne Pharma Group Limited.
Product Code: A04007
The global acne medication market was valued at $13.4 billion in 2023, and is estimated to reach $24.2 billion by 2035, growing at a CAGR of 5.1% from 2024 to 2035. Acne is a common skin condition characterized by the formulation of pimples, blackheads, whiteheads, cysts, or nodules, usually appearing on the face, chest, back, or shoulders. It occurs when hair follicles become clogged with oil and dead skin cells, leading to the proliferation of bacteria and inflammation. Several factors contribute to the development of acne, including hormonal fluctuations, genetics, excess oil production, bacteria, and certain medications or cosmetics. The treatment includes retinoid, antibiotic, salicylic acid, benzoyl peroxide, and other medications.
Acne Medication Market - IMG1
The acne medication market is expected to register significant growth due to rise in incidences of acne and unhealthy diet. Acne is one of the most common skin conditions globally, affecting individuals of all ages, genders, and ethnicities. Its prevalence has been steadily increasing over the years, driven by factors such as hormonal changes, environmental influences, dietary habits, and lifestyle choices. According to a 2023 article by the National Library of Medicine, acne vulgaris is commonly observed in adolescents and young adults. Prevalence rate of acne vulgaris is estimated to range from 35% to over 90% among adolescents. Thus, rise in the prevalence of acne is expected to drive the growth of the market.Furthermore, an unhealthy lifestyle serves as a significant driver for the acne medication market. Lifestyle factors such as poor dietary habits, high stress levels, inadequate sleep, and exposure to environmental pollutants contribute to the development and exacerbation of acne. Unbalanced diets high in refined sugars, processed foods, and dairy products can trigger hormonal fluctuations and increase sebum production, both of which are key factors in acne formulation. In addition, elevated stress levels stimulate the release of stress hormones like cortisol, which can lead to inflammation and exacerbate existing acne lesions. According to a 2023 article by Anxiety and Depression Association of America, it was reported that Generalized Anxiety Disorder affects 6.8 million adults or 3.1% of the U.S. population. Furthermore, insufficient sleep disrupts the body's natural healing processes and weakens the immune system, making individuals more susceptible to bacterial infections and inflammation associated with acne. Thus, the unhealthy lifestyle has resulted in growing incidence of acne resulting in increase in demand for acne medication.The acne medication market is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and region. By therapeutic class, the market is divided into retinoid, antibiotic, salicylic acid, benzoyl peroxide, and others. By formulation, the market is classified into topical and oral medication. By type, the market is distributed into prescription medicine and over-the-counter medicines. By acne type, the market is distributed into non-inflammatory acne and inflammatory acne. By distribution channel, the market is classified into retail stores, pharmacy and drug stores, and e-commerce. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)Major key players operating in the acne medication market are Bausch Health Companies Inc., Mayne Pharma Group Limited, Sun Pharmaceutical Industries Limited, Johnson and Johnson, GlaxoSmithKline Plc, Mylan N.V., Almirall Sa, Galderma S.A., Teva Pharmaceutical Industries Ltd., and Pfizer Inc. Key players have adopted acquisition as a key developmental strategy to improve the product portfolio of the acne medication market

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the acne medication market analysis from 2023 to 2035 to identify the prevailing acne medication market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the acne medication market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global acne medication market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Prescription Medicine
  • Over-the-counter medicines

By Therapeutic Class

  • Other medications
  • Retinoid
    • Type
    • Topical and Combination retinoid
    • Oral Retinoid
  • Antibiotic
    • Type
    • Topical and Combination Antibiotics
    • Oral Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide

By Acne Type

  • Non-inflammatory acne
  • Inflammatory acne

By Formulation

  • Topical Medication
  • Oral Medication

By Distribution Channel

  • Retail Store
  • Pharmacy and Drug Store
  • E-Commerce

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • AbbVie Inc.
    • Botanix Pharmaceuticals
    • Galderma S.A.
    • Bausch Health Companies Inc
    • GlaxoSmithKline Plc.
    • Bayer AG
    • Kenvue Inc
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mayne Pharma Group Limited.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Retinoid
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Retinoid Acne Medication Market by Type
  • 4.3. Antibiotic
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Antibiotic Acne Medication Market by Type
  • 4.4. Salicylic Acid
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Benzoyl Peroxide
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Other medications
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: ACNE MEDICATION MARKET, BY FORMULATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Topical Medication
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Oral Medication
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: ACNE MEDICATION MARKET, BY TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Prescription Medicine
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Over-the-counter medicines
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: ACNE MEDICATION MARKET, BY ACNE TYPE

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Non-inflammatory acne
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Inflammatory acne
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country

CHAPTER 8: ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Retail Store
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. Pharmacy and Drug Store
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. E-Commerce
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country

CHAPTER 9: ACNE MEDICATION MARKET, BY REGION

  • 9.1. Overview
    • 9.1.1. Market size and forecast By Region
  • 9.2. North America
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by Therapeutic Class
    • 9.2.3. Market size and forecast, by Formulation
    • 9.2.4. Market size and forecast, by Type
    • 9.2.5. Market size and forecast, by Acne Type
    • 9.2.6. Market size and forecast, by Distribution Channel
    • 9.2.7. Market size and forecast, by country
      • 9.2.7.1. U.S.
      • 9.2.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.2.7.1.2. Market size and forecast, by Formulation
      • 9.2.7.1.3. Market size and forecast, by Type
      • 9.2.7.1.4. Market size and forecast, by Acne Type
      • 9.2.7.1.5. Market size and forecast, by Distribution Channel
      • 9.2.7.2. Canada
      • 9.2.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.2.7.2.2. Market size and forecast, by Formulation
      • 9.2.7.2.3. Market size and forecast, by Type
      • 9.2.7.2.4. Market size and forecast, by Acne Type
      • 9.2.7.2.5. Market size and forecast, by Distribution Channel
      • 9.2.7.3. Mexico
      • 9.2.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.2.7.3.2. Market size and forecast, by Formulation
      • 9.2.7.3.3. Market size and forecast, by Type
      • 9.2.7.3.4. Market size and forecast, by Acne Type
      • 9.2.7.3.5. Market size and forecast, by Distribution Channel
  • 9.3. Europe
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by Therapeutic Class
    • 9.3.3. Market size and forecast, by Formulation
    • 9.3.4. Market size and forecast, by Type
    • 9.3.5. Market size and forecast, by Acne Type
    • 9.3.6. Market size and forecast, by Distribution Channel
    • 9.3.7. Market size and forecast, by country
      • 9.3.7.1. Germany
      • 9.3.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.1.2. Market size and forecast, by Formulation
      • 9.3.7.1.3. Market size and forecast, by Type
      • 9.3.7.1.4. Market size and forecast, by Acne Type
      • 9.3.7.1.5. Market size and forecast, by Distribution Channel
      • 9.3.7.2. France
      • 9.3.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.2.2. Market size and forecast, by Formulation
      • 9.3.7.2.3. Market size and forecast, by Type
      • 9.3.7.2.4. Market size and forecast, by Acne Type
      • 9.3.7.2.5. Market size and forecast, by Distribution Channel
      • 9.3.7.3. UK
      • 9.3.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.3.2. Market size and forecast, by Formulation
      • 9.3.7.3.3. Market size and forecast, by Type
      • 9.3.7.3.4. Market size and forecast, by Acne Type
      • 9.3.7.3.5. Market size and forecast, by Distribution Channel
      • 9.3.7.4. Italy
      • 9.3.7.4.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.4.2. Market size and forecast, by Formulation
      • 9.3.7.4.3. Market size and forecast, by Type
      • 9.3.7.4.4. Market size and forecast, by Acne Type
      • 9.3.7.4.5. Market size and forecast, by Distribution Channel
      • 9.3.7.5. Spain
      • 9.3.7.5.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.5.2. Market size and forecast, by Formulation
      • 9.3.7.5.3. Market size and forecast, by Type
      • 9.3.7.5.4. Market size and forecast, by Acne Type
      • 9.3.7.5.5. Market size and forecast, by Distribution Channel
      • 9.3.7.6. Rest of Europe
      • 9.3.7.6.1. Market size and forecast, by Therapeutic Class
      • 9.3.7.6.2. Market size and forecast, by Formulation
      • 9.3.7.6.3. Market size and forecast, by Type
      • 9.3.7.6.4. Market size and forecast, by Acne Type
      • 9.3.7.6.5. Market size and forecast, by Distribution Channel
  • 9.4. Asia-Pacific
    • 9.4.1. Key market trends, growth factors and opportunities
    • 9.4.2. Market size and forecast, by Therapeutic Class
    • 9.4.3. Market size and forecast, by Formulation
    • 9.4.4. Market size and forecast, by Type
    • 9.4.5. Market size and forecast, by Acne Type
    • 9.4.6. Market size and forecast, by Distribution Channel
    • 9.4.7. Market size and forecast, by country
      • 9.4.7.1. Japan
      • 9.4.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.1.2. Market size and forecast, by Formulation
      • 9.4.7.1.3. Market size and forecast, by Type
      • 9.4.7.1.4. Market size and forecast, by Acne Type
      • 9.4.7.1.5. Market size and forecast, by Distribution Channel
      • 9.4.7.2. China
      • 9.4.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.2.2. Market size and forecast, by Formulation
      • 9.4.7.2.3. Market size and forecast, by Type
      • 9.4.7.2.4. Market size and forecast, by Acne Type
      • 9.4.7.2.5. Market size and forecast, by Distribution Channel
      • 9.4.7.3. Australia
      • 9.4.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.3.2. Market size and forecast, by Formulation
      • 9.4.7.3.3. Market size and forecast, by Type
      • 9.4.7.3.4. Market size and forecast, by Acne Type
      • 9.4.7.3.5. Market size and forecast, by Distribution Channel
      • 9.4.7.4. India
      • 9.4.7.4.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.4.2. Market size and forecast, by Formulation
      • 9.4.7.4.3. Market size and forecast, by Type
      • 9.4.7.4.4. Market size and forecast, by Acne Type
      • 9.4.7.4.5. Market size and forecast, by Distribution Channel
      • 9.4.7.5. South Korea
      • 9.4.7.5.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.5.2. Market size and forecast, by Formulation
      • 9.4.7.5.3. Market size and forecast, by Type
      • 9.4.7.5.4. Market size and forecast, by Acne Type
      • 9.4.7.5.5. Market size and forecast, by Distribution Channel
      • 9.4.7.6. Rest of Asia-Pacific
      • 9.4.7.6.1. Market size and forecast, by Therapeutic Class
      • 9.4.7.6.2. Market size and forecast, by Formulation
      • 9.4.7.6.3. Market size and forecast, by Type
      • 9.4.7.6.4. Market size and forecast, by Acne Type
      • 9.4.7.6.5. Market size and forecast, by Distribution Channel
  • 9.5. LAMEA
    • 9.5.1. Key market trends, growth factors and opportunities
    • 9.5.2. Market size and forecast, by Therapeutic Class
    • 9.5.3. Market size and forecast, by Formulation
    • 9.5.4. Market size and forecast, by Type
    • 9.5.5. Market size and forecast, by Acne Type
    • 9.5.6. Market size and forecast, by Distribution Channel
    • 9.5.7. Market size and forecast, by country
      • 9.5.7.1. Brazil
      • 9.5.7.1.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.1.2. Market size and forecast, by Formulation
      • 9.5.7.1.3. Market size and forecast, by Type
      • 9.5.7.1.4. Market size and forecast, by Acne Type
      • 9.5.7.1.5. Market size and forecast, by Distribution Channel
      • 9.5.7.2. Saudi Arabia
      • 9.5.7.2.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.2.2. Market size and forecast, by Formulation
      • 9.5.7.2.3. Market size and forecast, by Type
      • 9.5.7.2.4. Market size and forecast, by Acne Type
      • 9.5.7.2.5. Market size and forecast, by Distribution Channel
      • 9.5.7.3. South Africa
      • 9.5.7.3.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.3.2. Market size and forecast, by Formulation
      • 9.5.7.3.3. Market size and forecast, by Type
      • 9.5.7.3.4. Market size and forecast, by Acne Type
      • 9.5.7.3.5. Market size and forecast, by Distribution Channel
      • 9.5.7.4. Rest of LAMEA
      • 9.5.7.4.1. Market size and forecast, by Therapeutic Class
      • 9.5.7.4.2. Market size and forecast, by Formulation
      • 9.5.7.4.3. Market size and forecast, by Type
      • 9.5.7.4.4. Market size and forecast, by Acne Type
      • 9.5.7.4.5. Market size and forecast, by Distribution Channel

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top winning strategies
  • 10.3. Product mapping of top 10 player
  • 10.4. Competitive dashboard
  • 10.5. Competitive heatmap
  • 10.6. Top player positioning, 2023

CHAPTER 11: COMPANY PROFILES

  • 11.1. AbbVie Inc.
    • 11.1.1. Company overview
    • 11.1.2. Key executives
    • 11.1.3. Company snapshot
    • 11.1.4. Operating business segments
    • 11.1.5. Product portfolio
    • 11.1.6. Business performance
    • 11.1.7. Key strategic moves and developments
  • 11.2. Botanix Pharmaceuticals
    • 11.2.1. Company overview
    • 11.2.2. Key executives
    • 11.2.3. Company snapshot
    • 11.2.4. Operating business segments
    • 11.2.5. Product portfolio
    • 11.2.6. Business performance
    • 11.2.7. Key strategic moves and developments
  • 11.3. Galderma S.A.
    • 11.3.1. Company overview
    • 11.3.2. Key executives
    • 11.3.3. Company snapshot
    • 11.3.4. Operating business segments
    • 11.3.5. Product portfolio
    • 11.3.6. Business performance
    • 11.3.7. Key strategic moves and developments
  • 11.4. Bausch Health Companies Inc
    • 11.4.1. Company overview
    • 11.4.2. Key executives
    • 11.4.3. Company snapshot
    • 11.4.4. Operating business segments
    • 11.4.5. Product portfolio
    • 11.4.6. Business performance
    • 11.4.7. Key strategic moves and developments
  • 11.5. GlaxoSmithKline Plc.
    • 11.5.1. Company overview
    • 11.5.2. Key executives
    • 11.5.3. Company snapshot
    • 11.5.4. Operating business segments
    • 11.5.5. Product portfolio
    • 11.5.6. Business performance
    • 11.5.7. Key strategic moves and developments
  • 11.6. Bayer AG
    • 11.6.1. Company overview
    • 11.6.2. Key executives
    • 11.6.3. Company snapshot
    • 11.6.4. Operating business segments
    • 11.6.5. Product portfolio
    • 11.6.6. Business performance
    • 11.6.7. Key strategic moves and developments
  • 11.7. Kenvue Inc
    • 11.7.1. Company overview
    • 11.7.2. Key executives
    • 11.7.3. Company snapshot
    • 11.7.4. Operating business segments
    • 11.7.5. Product portfolio
    • 11.7.6. Business performance
    • 11.7.7. Key strategic moves and developments
  • 11.8. Pfizer Inc.
    • 11.8.1. Company overview
    • 11.8.2. Key executives
    • 11.8.3. Company snapshot
    • 11.8.4. Operating business segments
    • 11.8.5. Product portfolio
    • 11.8.6. Business performance
    • 11.8.7. Key strategic moves and developments
  • 11.9. Teva Pharmaceutical Industries Ltd.
    • 11.9.1. Company overview
    • 11.9.2. Key executives
    • 11.9.3. Company snapshot
    • 11.9.4. Operating business segments
    • 11.9.5. Product portfolio
    • 11.9.6. Business performance
    • 11.9.7. Key strategic moves and developments
  • 11.10. Mayne Pharma Group Limited.
    • 11.10.1. Company overview
    • 11.10.2. Key executives
    • 11.10.3. Company snapshot
    • 11.10.4. Operating business segments
    • 11.10.5. Product portfolio
    • 11.10.6. Business performance
    • 11.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 02. ACNE MEDICATION MARKET FOR RETINOID, BY REGION, 2023-2035 ($MILLION)
  • TABLE 03. GLOBAL RETINOID ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 04. ACNE MEDICATION MARKET FOR ANTIBIOTIC, BY REGION, 2023-2035 ($MILLION)
  • TABLE 05. GLOBAL ANTIBIOTIC ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 06. ACNE MEDICATION MARKET FOR SALICYLIC ACID, BY REGION, 2023-2035 ($MILLION)
  • TABLE 07. ACNE MEDICATION MARKET FOR BENZOYL PEROXIDE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 08. ACNE MEDICATION MARKET FOR OTHER MEDICATIONS, BY REGION, 2023-2035 ($MILLION)
  • TABLE 09. GLOBAL ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 10. ACNE MEDICATION MARKET FOR TOPICAL MEDICATION, BY REGION, 2023-2035 ($MILLION)
  • TABLE 11. ACNE MEDICATION MARKET FOR ORAL MEDICATION, BY REGION, 2023-2035 ($MILLION)
  • TABLE 12. GLOBAL ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 13. ACNE MEDICATION MARKET FOR PRESCRIPTION MEDICINE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 14. ACNE MEDICATION MARKET FOR OVER-THE-COUNTER MEDICINES, BY REGION, 2023-2035 ($MILLION)
  • TABLE 15. GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 16. ACNE MEDICATION MARKET FOR NON-INFLAMMATORY ACNE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 17. ACNE MEDICATION MARKET FOR INFLAMMATORY ACNE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 18. GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 19. ACNE MEDICATION MARKET FOR RETAIL STORE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 20. ACNE MEDICATION MARKET FOR PHARMACY AND DRUG STORE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 21. ACNE MEDICATION MARKET FOR E-COMMERCE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 22. ACNE MEDICATION MARKET, BY REGION, 2023-2035 ($MILLION)
  • TABLE 23. NORTH AMERICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 24. NORTH AMERICA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 25. NORTH AMERICA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 26. NORTH AMERICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 27. NORTH AMERICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 28. NORTH AMERICA ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 29. U.S. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 30. U.S. ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 31. U.S. ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 32. U.S. ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 33. U.S. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 34. CANADA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 35. CANADA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 36. CANADA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 37. CANADA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 38. CANADA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 39. MEXICO ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 40. MEXICO ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 41. MEXICO ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 42. MEXICO ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 43. MEXICO ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 44. EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 45. EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 46. EUROPE ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 47. EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 48. EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 49. EUROPE ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 50. GERMANY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 51. GERMANY ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 52. GERMANY ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 53. GERMANY ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 54. GERMANY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 55. FRANCE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 56. FRANCE ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 57. FRANCE ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 58. FRANCE ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 59. FRANCE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 60. UK ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 61. UK ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 62. UK ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 63. UK ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 64. UK ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 65. ITALY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 66. ITALY ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 67. ITALY ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 68. ITALY ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 69. ITALY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 70. SPAIN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 71. SPAIN ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 72. SPAIN ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 73. SPAIN ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 74. SPAIN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 75. REST OF EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 76. REST OF EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 77. REST OF EUROPE ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 78. REST OF EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 79. REST OF EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 80. ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 81. ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 82. ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 83. ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 84. ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 85. ASIA-PACIFIC ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 86. JAPAN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 87. JAPAN ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 88. JAPAN ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 89. JAPAN ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 90. JAPAN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 91. CHINA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 92. CHINA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 93. CHINA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 94. CHINA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 95. CHINA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 96. AUSTRALIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 97. AUSTRALIA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 98. AUSTRALIA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 99. AUSTRALIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 100. AUSTRALIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 101. INDIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 102. INDIA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 103. INDIA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 104. INDIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 105. INDIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 106. SOUTH KOREA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 107. SOUTH KOREA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 108. SOUTH KOREA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 109. SOUTH KOREA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 110. SOUTH KOREA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 111. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 112. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 113. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 114. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 115. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 116. LAMEA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 117. LAMEA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 118. LAMEA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 119. LAMEA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 120. LAMEA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 121. LAMEA ACNE MEDICATION MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 122. BRAZIL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 123. BRAZIL ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 124. BRAZIL ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 125. BRAZIL ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 126. BRAZIL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 127. SAUDI ARABIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 128. SAUDI ARABIA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 129. SAUDI ARABIA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 130. SAUDI ARABIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 131. SAUDI ARABIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 132. SOUTH AFRICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 133. SOUTH AFRICA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 134. SOUTH AFRICA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 135. SOUTH AFRICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 136. SOUTH AFRICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 137. REST OF LAMEA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023-2035 ($MILLION)
  • TABLE 138. REST OF LAMEA ACNE MEDICATION MARKET, BY FORMULATION, 2023-2035 ($MILLION)
  • TABLE 139. REST OF LAMEA ACNE MEDICATION MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 140. REST OF LAMEA ACNE MEDICATION MARKET, BY ACNE TYPE, 2023-2035 ($MILLION)
  • TABLE 141. REST OF LAMEA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 ($MILLION)
  • TABLE 142. ABBVIE INC.: KEY EXECUTIVES
  • TABLE 143. ABBVIE INC.: COMPANY SNAPSHOT
  • TABLE 144. ABBVIE INC.: PRODUCT SEGMENTS
  • TABLE 145. ABBVIE INC.: SERVICE SEGMENTS
  • TABLE 146. ABBVIE INC.: PRODUCT PORTFOLIO
  • TABLE 147. ABBVIE INC.: KEY STRATEGIES
  • TABLE 148. BOTANIX PHARMACEUTICALS: KEY EXECUTIVES
  • TABLE 149. BOTANIX PHARMACEUTICALS: COMPANY SNAPSHOT
  • TABLE 150. BOTANIX PHARMACEUTICALS: PRODUCT SEGMENTS
  • TABLE 151. BOTANIX PHARMACEUTICALS: SERVICE SEGMENTS
  • TABLE 152. BOTANIX PHARMACEUTICALS: PRODUCT PORTFOLIO
  • TABLE 153. BOTANIX PHARMACEUTICALS: KEY STRATEGIES
  • TABLE 154. GALDERMA S.A.: KEY EXECUTIVES
  • TABLE 155. GALDERMA S.A.: COMPANY SNAPSHOT
  • TABLE 156. GALDERMA S.A.: PRODUCT SEGMENTS
  • TABLE 157. GALDERMA S.A.: SERVICE SEGMENTS
  • TABLE 158. GALDERMA S.A.: PRODUCT PORTFOLIO
  • TABLE 159. GALDERMA S.A.: KEY STRATEGIES
  • TABLE 160. BAUSCH HEALTH COMPANIES INC: KEY EXECUTIVES
  • TABLE 161. BAUSCH HEALTH COMPANIES INC: COMPANY SNAPSHOT
  • TABLE 162. BAUSCH HEALTH COMPANIES INC: PRODUCT SEGMENTS
  • TABLE 163. BAUSCH HEALTH COMPANIES INC: SERVICE SEGMENTS
  • TABLE 164. BAUSCH HEALTH COMPANIES INC: PRODUCT PORTFOLIO
  • TABLE 165. BAUSCH HEALTH COMPANIES INC: KEY STRATEGIES
  • TABLE 166. GLAXOSMITHKLINE PLC.: KEY EXECUTIVES
  • TABLE 167. GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
  • TABLE 168. GLAXOSMITHKLINE PLC.: PRODUCT SEGMENTS
  • TABLE 169. GLAXOSMITHKLINE PLC.: SERVICE SEGMENTS
  • TABLE 170. GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
  • TABLE 171. GLAXOSMITHKLINE PLC.: KEY STRATEGIES
  • TABLE 172. BAYER AG: KEY EXECUTIVES
  • TABLE 173. BAYER AG: COMPANY SNAPSHOT
  • TABLE 174. BAYER AG: PRODUCT SEGMENTS
  • TABLE 175. BAYER AG: SERVICE SEGMENTS
  • TABLE 176. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 177. BAYER AG: KEY STRATEGIES
  • TABLE 178. KENVUE INC: KEY EXECUTIVES
  • TABLE 179. KENVUE INC: COMPANY SNAPSHOT
  • TABLE 180. KENVUE INC: PRODUCT SEGMENTS
  • TABLE 181. KENVUE INC: SERVICE SEGMENTS
  • TABLE 182. KENVUE INC: PRODUCT PORTFOLIO
  • TABLE 183. KENVUE INC: KEY STRATEGIES
  • TABLE 184. PFIZER INC.: KEY EXECUTIVES
  • TABLE 185. PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 186. PFIZER INC.: PRODUCT SEGMENTS
  • TABLE 187. PFIZER INC.: SERVICE SEGMENTS
  • TABLE 188. PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 189. PFIZER INC.: KEY STRATEGIES
  • TABLE 190. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
  • TABLE 191. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
  • TABLE 192. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SEGMENTS
  • TABLE 193. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SERVICE SEGMENTS
  • TABLE 194. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
  • TABLE 195. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIES
  • TABLE 196. MAYNE PHARMA GROUP LIMITED.: KEY EXECUTIVES
  • TABLE 197. MAYNE PHARMA GROUP LIMITED.: COMPANY SNAPSHOT
  • TABLE 198. MAYNE PHARMA GROUP LIMITED.: PRODUCT SEGMENTS
  • TABLE 199. MAYNE PHARMA GROUP LIMITED.: SERVICE SEGMENTS
  • TABLE 200. MAYNE PHARMA GROUP LIMITED.: PRODUCT PORTFOLIO
  • TABLE 201. MAYNE PHARMA GROUP LIMITED.: KEY STRATEGIES

LIST OF FIGURES

  • FIGURE 01. ACNE MEDICATION MARKET, 2023-2035
  • FIGURE 02. SEGMENTATION OF ACNE MEDICATION MARKET,2023-2035
  • FIGURE 03. TOP IMPACTING FACTORS IN ACNE MEDICATION MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN ACNE MEDICATION MARKET (2024-2035)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL ACNE MEDICATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2023 AND 2035(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR RETINOID, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR ANTIBIOTIC, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR SALICYLIC ACID, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR BENZOYL PEROXIDE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR OTHER MEDICATIONS, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 17. ACNE MEDICATION MARKET, BY FORMULATION, 2023 AND 2035(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR TOPICAL MEDICATION, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR ORAL MEDICATION, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 20. ACNE MEDICATION MARKET, BY TYPE, 2023 AND 2035(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR PRESCRIPTION MEDICINE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR OVER-THE-COUNTER MEDICINES, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 23. ACNE MEDICATION MARKET, BY ACNE TYPE, 2023 AND 2035(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR NON-INFLAMMATORY ACNE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR INFLAMMATORY ACNE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 26. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2023 AND 2035(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR RETAIL STORE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR PHARMACY AND DRUG STORE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ACNE MEDICATION MARKET FOR E-COMMERCE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 30. ACNE MEDICATION MARKET BY REGION, 2023 AND 2035(%)
  • FIGURE 31. U.S. ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 32. CANADA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 33. MEXICO ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 34. GERMANY ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 35. FRANCE ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 36. UK ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 37. ITALY ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 38. SPAIN ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 39. REST OF EUROPE ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 40. JAPAN ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 41. CHINA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 42. AUSTRALIA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 43. INDIA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 44. SOUTH KOREA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 46. BRAZIL ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 47. SAUDI ARABIA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 48. SOUTH AFRICA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 49. REST OF LAMEA ACNE MEDICATION MARKET, 2023-2035 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: ACNE MEDICATION MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2023